Alphabet’s Isomorphic Labs raises $600 million to advance AI drug design
Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and ...
Demis Hassabis on Isomorphic’s $600 million raise, AI, and healthcare’s future
Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, ...
Alphabet’s Isomorphic Labs raises $600M in first funding round for AI drug business
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
Alphabet spinout Isomorphic Labs raises $600M for its AI drug design engine
AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...
Fierce Biotech2d
Alphabet's AI biotech Isomorphic Labs hauls in $600M to power next-gen drug design model
AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...
Google-backed AI drug discovery startup raises $600 million
Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...
GlobalData on MSN2d
Google-backed Isomorphic Labs raises $600m to advance AI drug discovery
The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.
Isomorphic raises $600M on big ambitions for AI drugmaking tech
The drug discovery company, which has partnerships with Eli Lilly and Novartis, is developing AI models to design drugs and ...
pharmaphorum2d
Alphabet's Isomorphic raises $600m for AI drug discovery
Lilly and Novartis have collectively pledged almost $3 billion to their partnerships with Isomorphic signed last year, which ...